Skip to main content
Top
Published in: Journal of Nephrology 1/2014

01-02-2014 | Original Article

Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit

Authors: Pia Lebiedz, Lilli Knickel, Christiane Engelbertz, Florian Lüders, Katrin Gebauer, Wolfgang E. Berdel, Johannes Waltenberger, Holger Reinecke

Published in: Journal of Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Chronic kidney disease (CKD) increases acute and long-term mortality of many diseases. Limited data are available, in how far a preexisting non-dialysis dependent CKD affects the outcome of critically ill patients treated for non-renal causes.

Methods

In a retrospective study, we assessed the outcome of 524 patients with need for mechanical ventilation at our medical intensive care unit between 2002 and 2007. Patients were divided into 5 CKD stages depending on their calculated glomerular filtration rate at hospital admission excluding patients with pre-existing end-stage renal failure. In-hospital and long-term outcome up to 5 years were assessed.

Results

Advanced stages of CKD at admission were associated with higher age (p < 0.001) and diabetes (p = 0.003). Patients with higher CKD stages suffered more often from acute renal failure (p < 0.001), required longer renal replacement therapy (p < 0.001) and more often in-hospital resuscitation (p = 0.019). 405 patients died during follow-up (226 in-hospital). Multivariate Cox regression analysis identified eGFR as independent predictor of 30-day- (HRR 0.994, 95 % CI 0.990–0.998) and 1-year-mortality (HRR 0.996, 95 % CI 0.993–1.000). Long-term survival decreased significantly with increasing CKD stages (p = 0.004) and occurrence of acute renal failure (p < 0.001).

Conclusions

In critically ill patients requiring mechanical ventilation, preexisting non-dialysis dependent CKD has marked impact on occurrence of acute renal failure, 30-day- and 1-year-mortality.
Literature
1.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef
2.
go back to reference Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47–55PubMedCrossRef Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47–55PubMedCrossRef
3.
go back to reference McCullough PA (2003) Why is chronic kidney disease the “spoiler” for cardiovascular outcomes? J Am Coll Cardiol 41:725–728PubMedCrossRef McCullough PA (2003) Why is chronic kidney disease the “spoiler” for cardiovascular outcomes? J Am Coll Cardiol 41:725–728PubMedCrossRef
4.
go back to reference Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS (2013) Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127:569–574PubMedCentralPubMedCrossRef Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS (2013) Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127:569–574PubMedCentralPubMedCrossRef
5.
go back to reference Reinecke H, Brand E, Mesters R et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705–711PubMedCrossRef Reinecke H, Brand E, Mesters R et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705–711PubMedCrossRef
6.
go back to reference Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142PubMedCrossRef Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142PubMedCrossRef
7.
go back to reference Zamora E, Lupón J, Vila J et al (2012) Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardiol 59:1709–1715PubMedCrossRef Zamora E, Lupón J, Vila J et al (2012) Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardiol 59:1709–1715PubMedCrossRef
8.
go back to reference Swedberg K, Young JB, Anand IS et al (2013) Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219PubMedCrossRef Swedberg K, Young JB, Anand IS et al (2013) Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219PubMedCrossRef
9.
go back to reference Anavekar NS, McMurray JJ, Velazquez EJ et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285–1295PubMedCrossRef Anavekar NS, McMurray JJ, Velazquez EJ et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285–1295PubMedCrossRef
10.
go back to reference Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63:696–701PubMedCrossRef Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63:696–701PubMedCrossRef
11.
go back to reference Szummer K, Lundman P, Jacobson SH et al (2009) Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction. SWEDEHEART. Circulation 120:851–858PubMedCrossRef Szummer K, Lundman P, Jacobson SH et al (2009) Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction. SWEDEHEART. Circulation 120:851–858PubMedCrossRef
12.
13.
go back to reference Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047PubMedCrossRef Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047PubMedCrossRef
14.
go back to reference National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
15.
go back to reference Meguid El Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340PubMedCrossRef Meguid El Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340PubMedCrossRef
16.
go back to reference Arulkumaran N, Annear NM, Singer M (2013) Patients with end-stage renal disease admitted to the intensive care unit: systematic review. Br J Anaesth 110:13–20PubMedCrossRef Arulkumaran N, Annear NM, Singer M (2013) Patients with end-stage renal disease admitted to the intensive care unit: systematic review. Br J Anaesth 110:13–20PubMedCrossRef
17.
go back to reference Hölscher B, Heitmeyer C, Fobker M, Breithardt G, Schaefer RM, Reinecke H (2008) Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled dialysis-versus-diuresis (DVD) trial. Can J Cardiol 24:845–850PubMedCrossRef Hölscher B, Heitmeyer C, Fobker M, Breithardt G, Schaefer RM, Reinecke H (2008) Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled dialysis-versus-diuresis (DVD) trial. Can J Cardiol 24:845–850PubMedCrossRef
18.
go back to reference Wald R, Quinn RR, Adhikari NK et al (2012) Risk of chronic dialysis and death following acute kidney injury. Am J Med 125:585–593PubMedCrossRef Wald R, Quinn RR, Adhikari NK et al (2012) Risk of chronic dialysis and death following acute kidney injury. Am J Med 125:585–593PubMedCrossRef
19.
go back to reference Hotchkiss JR, Palevsky PM (2012) Care of the critically ill patient with advanced chronic kidney disease or end-stage renal disease. Curr Opin Crit Care 18:599–606PubMedCrossRef Hotchkiss JR, Palevsky PM (2012) Care of the critically ill patient with advanced chronic kidney disease or end-stage renal disease. Curr Opin Crit Care 18:599–606PubMedCrossRef
20.
go back to reference Fortrie G, Stads S, de Geus HR, Groeneveld AB, Zietse R, Betjes MG (2013) Determinants of renal function at hospital discharge of patients treated with renal replacement therapy in the intensive care unit. J Crit Care 28:126–132PubMedCrossRef Fortrie G, Stads S, de Geus HR, Groeneveld AB, Zietse R, Betjes MG (2013) Determinants of renal function at hospital discharge of patients treated with renal replacement therapy in the intensive care unit. J Crit Care 28:126–132PubMedCrossRef
21.
go back to reference Bell M, Granath F, Schön S et al (2008) End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome. Crit Care Med 36:2773–2778PubMedCrossRef Bell M, Granath F, Schön S et al (2008) End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome. Crit Care Med 36:2773–2778PubMedCrossRef
22.
go back to reference Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS (2009) Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4:891–898PubMedCrossRef Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS (2009) Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4:891–898PubMedCrossRef
23.
go back to reference Gammelager H, Christiansen CF, Johansen MB, Tønnesen E, Jespersen B, Sørensen HT (2012) One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study. Crit Care 16:R124PubMedCrossRef Gammelager H, Christiansen CF, Johansen MB, Tønnesen E, Jespersen B, Sørensen HT (2012) One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study. Crit Care 16:R124PubMedCrossRef
24.
go back to reference Bagshaw SM, Mortis G, Doig CJ, Godinez-Luna T, Fick GH, Laupland KB (2006) One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am J Kidney Dis 48:402–409PubMedCrossRef Bagshaw SM, Mortis G, Doig CJ, Godinez-Luna T, Fick GH, Laupland KB (2006) One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am J Kidney Dis 48:402–409PubMedCrossRef
Metadata
Title
Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit
Authors
Pia Lebiedz
Lilli Knickel
Christiane Engelbertz
Florian Lüders
Katrin Gebauer
Wolfgang E. Berdel
Johannes Waltenberger
Holger Reinecke
Publication date
01-02-2014
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 1/2014
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-013-0016-1

Other articles of this Issue 1/2014

Journal of Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine